المؤلفون: De Silva MK; From the Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Chan DLH, Bernard EJ, Conner AJ; From the Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Mascall SL; From the Department of Medical Oncology, Royal North Shore Hospital, Sydney, New South Wales, Australia., Bailey DL, Roach PJ, Clarke SJ, Diakos CI, Pavlakis N, Schembri G

المصدر: Pancreas [Pancreas] 2024 Aug 01; Vol. 53 (7), pp. e560-e565.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8608542 Publication Model: Print Cited Medium: Internet ISSN: 1536-4828 (Electronic) Linking ISSN: 08853177 NLM ISO Abbreviation: Pancreas Subsets: MEDLINE

مواضيع طبية MeSH: Neuroendocrine Tumors*/pathology , Neuroendocrine Tumors*/radiotherapy , Neuroendocrine Tumors*/diagnostic imaging , Neuroendocrine Tumors*/metabolism , Neuroendocrine Tumors*/mortality , Fluorodeoxyglucose F18* , Octreotide*/analogs & derivatives , Octreotide*/therapeutic use , Radiopharmaceuticals* , Positron-Emission Tomography*/methods , Tumor Burden* , Organometallic Compounds*/therapeutic use, Humans ; Male ; Middle Aged ; Female ; Retrospective Studies ; Aged ; Prognosis ; Adult ; Receptors, Peptide/metabolism ; Glycolysis ; Aged, 80 and over ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/radiotherapy ; Pancreatic Neoplasms/diagnostic imaging ; Pancreatic Neoplasms/mortality ; Progression-Free Survival ; Treatment Outcome